
Oculomics: Why your routine eye exam is missing critical clues
Advanced imaging of the eye can detect early markers of systemic diseases like diabetes, hypertension, and neurodegenerative conditions, enabling proactive intervention.
Can mice learn to control their own brains? A new neurofeedback system
A real-time closed-loop neurofeedback system allowed mice to modulate cortical activity and movement, adapting to rule changes for reward acquisition.
Type 2 diabetes: What if insulin only needed to be weekly?
Insulin efsitora alfa represents a shift towards once-weekly basal insulin, aiming to simplify regimens and improve adherence for patients with type 2 diabetes.
Predictive CGM: Stop chasing nocturnal lows, prevent them
Predictive continuous glucose monitoring (CGM) technology offers a new approach to managing nocturnal hypoglycaemia, providing real-time alerts that allow for proactive intervention. This technology aims to reduce the fear and clinical burden associated wit...
Automated insulin delivery: Why pregnancy makes glucose control harder
Automated insulin delivery systems offer improved glucose control, but pregnancy and menstrual cycle variations present unique challenges for optimal management.
Is your diabetes care missing the full metabolic picture?
New technologies are moving beyond simple glucose monitoring to integrate additional biomarkers, offering a more comprehensive view of metabolic health in diabetes management.
Type 1 diabetes: Why managing insulin isn't enough anymore
Teplizumab represents a significant step in autoimmune type 1 diabetes management, moving beyond insulin replacement to target disease progression itself. Its mechanism offers a new approach to preserving beta-cell function.
Pneumococcal disease: Your patients need updated protection now
Pneumococcal disease remains a significant global health burden, with new GBD 2023 data highlighting persistent mortality in vulnerable populations.
Ventilation: Why static guidelines fail dynamic patients
Continuous-improvement ventilation relies on real-world data to refine protocols and enhance patient outcomes, moving beyond static guidelines.